Nuvasive Inc (NUVA) Gross Profit Margin starting from the second quarter 2023 to second quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Nuvasive Inc  (NASDAQ: NUVA)


Nuvasive Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUVA Gross Profit Margin (Jun 30 2023)
Q2 		(Mar 31 2023)
Q1 		(Dec 31 2022)
Q4 		(Sep 30 2022)
Q3 		(Jun 30 2022)
Q2
Y / Y Revenue Change 2.36 %
Seq. Revenue Change 3.27 %
Revenue In Millions $317.79
Gross Profit Margin 71.84 %
Gross Profit Margin Total Ranking # 1016
Gross Profit In Millions $228.31
Y / Y Gross Profit Change 1.61 %
Seq. Gross Profit Change 3.15 %


Commenting Second Quarter 2023 Gross Profit Margin
Nuvasive Inc has managed to improve its Revenue sequentially to $317.79 millions by 3.27 % faster than Gross Profit increase of 3.15 % to $228.31 millions, this led to contraction in Gross Profit Margin to 71.84 %, below company average.


Observing second quarter 2023 results within Medical Equipment & Supplies industry 52 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 984 to 1016.
Learn about Gross Margin
NUVA's Gross Profit Margin second quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 53
Healthcare Sector # 179
Overall # 999

Gross Profit Margin Statistics
High Average Low
77.24 % 73.33 % 60.46 %
(Dec 31 2014)   (Jun 30 2020)


NUVA Gross Income Trends • More of NUVA's Profitabilty Ratios • NUVA Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NUVA's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NUVA's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NUVA's Competitors
Gross Profit Margin Profit Margin for Nuvasive Inc's Suppliers
Gross Profit Margin Profit Margin for NUVA's Customers

You may also want to know
NUVA's Annual Growth Rates NUVA's Profitability Ratios NUVA's Asset Turnover Ratio NUVA's Dividend Growth
NUVA's Roe NUVA's Valuation Ratios NUVA's Financial Strength Ratios NUVA's Gross Profit Growth
NUVA's Roa NUVA's Inventory Turnover Ratio NUVA's Growth Rates NUVA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2023, within Medical Equipment & Supplies Industry Gross Profit MarginJun 30 2023 MRQ Gross ProfitJun 30 2023 MRQ Revenue
Orchestra Biomed Holdings Inc   94.10 %$ 0.861  Millions$ 0.915  Millions
Collplant Biotechnologies Ltd  93.96 %$ 9.569  Millions$ 10.184  Millions
Semler Scientific inc   93.45 %$ 17.386  Millions$ 18.605  Millions
Venus Concept Inc   93.43 %$ 14.220  Millions$ 15.220  Millions
Catheter Precision Inc   92.71 %$ 0.089  Millions$ 0.096  Millions
Vycor Medical Inc   91.76 %$ 0.443  Millions$ 0.483  Millions
Longduoduo Co Ltd  90.45 %$ 2.767  Millions$ 3.059  Millions
Neuraxis Inc   89.50 %$ 0.578  Millions$ 0.646  Millions
Cvrx inc   88.87 %$ 7.983  Millions$ 8.983  Millions
Inari Medical Inc   88.37 %$ 105.161  Millions$ 119.005  Millions
Sanara Medtech Inc   87.15 %$ 13.566  Millions$ 15.566  Millions
Sight Sciences Inc   87.01 %$ 20.090  Millions$ 23.090  Millions
Shockwave Medical Inc   86.64 %$ 155.672  Millions$ 179.672  Millions
Inspire Medical Systems inc   83.95 %$ 126.840  Millions$ 151.092  Millions
Vystar Corporation  83.63 %$ 0.030  Millions$ 0.036  Millions
Electrocore Inc   83.53 %$ 2.966  Millions$ 3.551  Millions
Fonar Corporation  83.30 %$ 21.472  Millions$ 25.776  Millions
Allurion Technologies Inc   83.29 %$ 9.968  Millions$ 11.968  Millions
Mimedx Group Inc   83.28 %$ 67.674  Millions$ 81.257  Millions
Trisalus Life Sciences Inc   83.26 %$ 3.840  Millions$ 4.612  Millions
Nuo Therapeutics Inc   82.66 %$ 0.098  Millions$ 0.118  Millions
Paragon 28 inc   82.63 %$ 42.151  Millions$ 51.009  Millions
Si bone inc   81.81 %$ 26.987  Millions$ 32.987  Millions
Treace Medical Concepts Inc   81.71 %$ 34.278  Millions$ 41.953  Millions
Icad Inc  81.30 %$ 4.349  Millions$ 5.349  Millions
Avita Medical Inc   81.25 %$ 9.549  Millions$ 11.753  Millions
Myomo Inc   81.06 %$ 4.281  Millions$ 5.281  Millions
Axogen inc   81.06 %$ 30.927  Millions$ 38.155  Millions
Sintx Technologies Inc   79.53 %$ 0.404  Millions$ 0.508  Millions
Zynex inc   79.37 %$ 35.680  Millions$ 44.952  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.